Source: BUSINESS WIRE

Press Release: Avaxia Biologics : Research and Markets: Gastrointestinal Radiation Toxicity Pipeline Review, H1 2015 - 3 Companies & 5 Drug Profiles

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/j3jsq3/gastrointestinal) has announced the addition of the "Gastrointestinal Radiation Toxicity - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Gastrointestinal Radiation Toxicity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administra

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Barbara S. Fox's photo - Founder & CEO of Avaxia Biologics

Founder & CEO

Barbara S. Fox

CEO Approval Rating

69/100

Read more